Application 021337
- Type
- NDA
- Sponsor
- MERCK SHARP DOHME
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | INVANZ | ERTAPENEM SODIUM | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | EQ 1GM BASE/VIAL | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021337-001 | INVANZ | ERTAPENEM SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021337-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021337-001 | INVANZ | EQ 1GM BASE/VIAL | INJECTABLE / INTRAMUSCULAR, INTRAVENOUS | AP | RLD, RS | 2001-11-21 | cb3db0bc1861… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021337-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021337-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021337-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021337-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021337-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021337-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021337-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021337-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021337-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021337-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021337-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021337-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021337-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N021337-001 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021337-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N021337-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N021337-001 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N021337-001 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021337-001 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N021337-001 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021337-001 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N021337-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N021337-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N021337-001 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N021337-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021337-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021337-001 | AP | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021337-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N021337-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N021337-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021337-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021337-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021337-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021337-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N021337-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N021337-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021337-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N021337-001 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N021337-001 | AP | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021337-001 | AP | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ERTAPENEM | ERTAPENEM SODIUM | ENDO USA, Inc. | 41304b1d-7db4-468a-ab1d-04e56fb50de4 | 2026-03-02 | Warnings, Adverse reactions | 021337 NDA021337 42023-221 |
| ERTAPENEM | ERTAPENEM SODIUM | ENDO USA, Inc. | 657855f2-7c92-4aa8-9c3d-51d08e56a09a | 2026-03-02 | Warnings, Adverse reactions | 021337 NDA021337 42023-221 |
| INVANZ | ERTAPENEM SODIUM | Merck Sharp & Dohme LLC | 33f3b99b-fa82-42e0-26bf-f49891ae3d22 | 2026-02-04 | Warnings, Adverse reactions | 021337 NDA021337 0006-3843 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0006-3843 | INVANZ | ertapenem sodium | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3843 | INVANZ | ertapenem sodium | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3843 | INVANZ | ertapenem sodium | Merck Sharp & Dohme LLC | NDA | Current |
| 0006-3843 | INVANZ | ertapenem sodium | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3843 | INVANZ | ertapenem sodium | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3843 | INVANZ | ertapenem sodium | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3843 | INVANZ | ertapenem sodium | Merck Sharp & Dohme Corp. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 70564 | SUPPL | 2022-03-21 |
| 70555 | SUPPL | 2022-03-18 |
| 65754 | SUPPL | 2020-12-28 |
| 65714 | SUPPL | 2020-12-23 |
| 60172 | SUPPL | 2019-10-01 |
| 60089 | SUPPL | 2019-09-23 |
| 56939 | SUPPL | 2018-12-21 |
| 56895 | SUPPL | 2018-12-20 |
| 55524 | SUPPL | 2018-09-19 |
| 55480 | SUPPL | 2018-09-14 |
| 49809 | SUPPL | 2017-09-20 |
| 49727 | SUPPL | 2017-09-13 |
| 15216 | SUPPL | 2014-10-02 |
| 5081 | SUPPL | 2014-10-02 |
| 42107 | SUPPL | 2014-01-16 |
| 36689 | SUPPL | 2013-07-30 |
| 27515 | SUPPL | 2013-07-26 |
| 15215 | SUPPL | 2012-03-07 |
| 5080 | SUPPL | 2012-03-05 |
| 15214 | SUPPL | 2012-02-22 |
| 15211 | SUPPL | 2011-07-25 |
| 5078 | SUPPL | 2011-07-25 |
| 15213 | SUPPL | 2010-05-28 |
| 27514 | SUPPL | 2010-05-27 |
| 5077 | SUPPL | 2010-01-25 |
| 36688 | SUPPL | 2009-12-15 |
| 5079 | SUPPL | 2009-11-10 |
| 15212 | SUPPL | 2009-10-14 |
| 36687 | SUPPL | 2008-03-27 |
| 5076 | SUPPL | 2008-03-26 |
| 5075 | SUPPL | 2007-11-19 |
| 5074 | SUPPL | 2006-08-14 |
| 36686 | SUPPL | 2006-08-11 |
| 36685 | SUPPL | 2005-10-19 |
| 27513 | SUPPL | 2005-10-19 |
| 36684 | SUPPL | 2005-05-20 |
| 5073 | SUPPL | 2005-05-20 |
| 27512 | SUPPL | 2005-01-26 |
| 27511 | SUPPL | 2004-09-10 |
| 5072 | SUPPL | 2004-05-26 |
| 27510 | SUPPL | 2004-05-04 |
| 36683 | ORIG | 2001-11-09 |
| 21608 | ORIG | 2001-11-09 |
| 5071 | ORIG | 2001-11-09 |
| 51850 | ORIG | 1900-01-01 |
| 51849 | ORIG | 1900-01-01 |
| 51848 | ORIG | 1900-01-01 |
| 51847 | ORIG | 1900-01-01 |